Allervarx
NDC 57483-955, Loratadine, tablet, orally disintegrating, from Innovus Pharmaceuticals, Inc..
- Product NDC
- 57483-955
- Status
- Listed
- Labeler
- Innovus Pharmaceuticals, Inc.
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA212795
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57483-955 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LORATADINE5 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57483-955-05 | 57483095505 | 3 BLISTER PACK in 1 CARTON (57483-955-05) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 57483-955 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57483-955 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57483-955. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.